An Investigation into Clinical Disease and Clinical Immunity to P. vivax Malaria

Karunaweera, Nadira Darshani

dc.contributor.author	Karunaweera, Nadira Darshani
dc.date.accessioned	2022-09-22T05:17:15Z
dc.date.available	2022-09-22T05:17:15Z
dc.date.issued	1993
dc.identifier.uri	http://archive.cmb.ac.lk:8080/xmlui/handle/70130/6895
dc.description	Degree: Ph.D; Colombo : Faculty of medicine	en_US
dc.description.abstract	Continuous exposure to endemic P.vivax malaria leads to the development of both an anti-parasite and a clinical immunity. The degreeand extent of clinical disease was measured in 47 adult p.vivax malaria patients exposed to endemic malaria. The studies indicate that clinical immunity to malaria is associated with low plasma cytokine levels. Hence the mechanisms involved in sustaining low cytokine levels in plasma could underlie the acquisition of clinical immunity to malaria	en_US
dc.language.iso	en	en_US
dc.publisher	Faculty of Medicine, University of Colombo	en_US
dc.subject	Plasmodium vivax	en_US
dc.subject	Malaria, Vivax	en_US
dc.subject	MALARIA	en_US
dc.title	An Investigation into Clinical Disease and Clinical Immunity to P. vivax Malaria	en_US
dc.type	Thesis	en_US